For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Tramadol hydrochloride - Pain
PAD Profile : Tramadol hydrochloride - Pain
Traffic Light Status
Status 1 of 7.
- Capsules
The Faculty of Pain Medicine has produced resources for healthcare professionals around opioid prescribing:http://www.fpm.ac.uk/faculty-of-pain-medicine/opioids-aware
Status 2 of 7.
- Modified release capsules
- Modified release tablets
The Faculty of Pain Medicine has produced resources for healthcare professionals around opioid prescribing:http://www.fpm.ac.uk/faculty-of-pain-medicine/opioids-aware
Status 3 of 7.
- Soluble tablets
Status 4 of 7.
- Oro-dispersible
Status 5 of 7.
- Oral solution
Status 6 of 7.
- Oral drops
Status 7 of 7.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Co-proxamol (Dextropropoxyphene hydrochloride/para
- Ziconotide acetate
- Oxycodone
- Co-codamol
- Tramadol with paracetamol
- Oxycodone with naloxone
- Fentanyl
- Tramadol with Dexketoprofen
- Paracetamol
- Codeine phosphate
- Dihydrocodeine tartrate
- Buprenorphine
- Morphine sulfate
- Pregabalin
- Gabapentin
- Cannabis (medicinal)
- Co-dydramol 10/500
- Sufentanil
- Ibuprofen
- Meptazinol hydrochloride
- Pethidine hydrochloride
- Diamorphine hydrochloride
- Methoxyflurane
- Alfentanil hydrochloride
- Co-dydramol 20/500
- Co-dydramol 30/500
- Nefopam hydrochloride
- Papaveretum
- Aspirin
- Parecoxib sodium
- Ketamine
Other Indications
Additional Documents
Committee Recommendations
It is recommended that tramadol modified release preparations are prescribed by BRAND - see UKMI Branded Prescribing Recommendations document below. The locally preferred brand for modified-release, TWICE DAILY dosing is Marol® Marol® is available across all of the twice-daily dose ranges, already represents the most commonly prescribed tramadol brand locally and nationally and remains one of the most cost-effective tramadol MR choices. Patients currently receiving generically written prescriptions should be reviewed with a view to change the prescribing to a cost-effective brand.
A stepped approach to pain management is recommended. Paracetamol is considered a 1st line option for the treatment of pain. A trial of tramadol (patient agreement) may be considered if maximum tolerated doses of codeine /dihydrocodeine are ineffective. Consider whether all measures have been taken to control side effects. Please refer to the guidelines attached:
Ensure a patient agreement is completed by the patient (see below) prior to a trial of tramadol.
PLEASE NOTE:
- Standard/Immediate release capsules should be prescribed GENERICALLY
- Modified release tablets should be prescribed by BRAND with Marol® being locally preferred (See below)